Video Game Study Paves Path For Pivotal FDA Trial To Treat Pediatric ADHD
This article was originally published in The Gray Sheet
A new video game treatment called Project: EVO being developed by Boston-based Akili Labs has crossed an important milestone with positive pilot study data for treating children with attention deficit hyperactivity disorder. The company is planning to launch a randomized, pivotal study to support FDA approval of a "prescription-strength video game" in the coming months.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.